Beta Bionics, Inc.
BBNX
$17.04
$0.331.98%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 249.72M | 231.47M | 103.58M | 60.90M | |
Total Receivables | 11.40M | 9.06M | 12.00M | 7.46M | |
Inventory | 17.32M | 15.73M | 13.32M | 11.29M | |
Prepaid Expenses | 5.34M | 3.44M | 2.98M | 2.60M | |
Finance Division Loans and Leases Current | -- | -- | -- | -- | |
Total Finance Division Other Current Assets | -- | -- | -- | -- | |
Other Current Assets | 2.30M | 2.21M | 1.05M | 305.00K | |
Total Current Assets | 286.08M | 261.92M | 132.92M | 82.56M | |
|
|||||
Total Current Assets | 286.08M | 261.92M | 132.92M | 82.56M | |
Net Property, Plant & Equipment | 12.50M | 11.86M | 11.42M | 11.04M | |
Long-term Investments | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | |
Total Other Intangibles | -- | -- | -- | -- | |
Finance Div Loans & Leases LT | -- | -- | -- | -- | |
Total Finance Div Other LT Assets | -- | -- | -- | -- | |
Total Other Assets | 244.00K | 246.00K | 5.30M | 3.35M | |
Total Assets | 329.97M | 338.02M | 149.65M | 96.94M | |
|
|||||
Total Accounts Payable | 3.42M | 3.45M | 2.85M | 2.85M | |
Total Accrued Expenses | 10.39M | 8.31M | 13.33M | 11.46M | |
Short-term Debt | -- | -- | -- | -- | |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
Finance Division Debt Current | 1.52M | 1.52M | 1.53M | 1.45M | |
Total Finance Division Other Current Liabilities | 4.16M | 3.21M | 3.44M | 2.12M | |
Total Other Current Liabilities | 4.16M | 3.21M | 3.44M | 2.12M | |
Total Current Liabilities | 19.49M | 16.49M | 21.15M | 17.88M | |
|
|||||
Total Current Liabilities | 19.49M | 16.49M | 21.15M | 17.88M | |
Long-Term Debt | -- | -- | -- | -- | |
Short-term Debt | -- | -- | -- | -- | |
Capital Leases | 5.17M | 5.45M | 5.73M | 5.85M | |
Finance Division Debt Non Current | -- | -- | -- | -- | |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
Total Other Liabilities | 3.68M | 2.33M | 46.76M | 40.34M | |
Total Liabilities | 28.34M | 24.27M | 73.63M | 64.07M | |
|
|||||
Common Stock & APIC | 643.75M | 638.91M | 51.31M | 49.72M | |
Retained Earnings | -342.26M | -325.39M | -296.74M | -278.63M | |
Treasury Stock & Other | 149.00K | 240.00K | 65.00K | 58.00K | |
Total Common Equity | 301.63M | 313.75M | -245.36M | -228.85M | |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | |
Preferred Stock Non Redeemable | -- | -- | -- | -- | |
Preferred Stock Convertible | -- | -- | 321.37M | 261.71M | |
Preferred Stock, Others | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | 321.37M | 261.71M | |
|
|||||
Total Common Equity | 301.63M | 313.75M | -245.36M | -228.85M | |
Total Preferred Equity | -- | -- | 321.37M | 261.71M | |
Total Minority Interest | -- | -- | -- | -- | |
Total Equity | 301.63M | 313.75M | 76.01M | 32.87M | |
|